In addition, ANXA2 has been identified as a target of miR-155, an important microRNA involved in neuroinflammation at the blood–brain barrier [89] and crucial in the development of Th1 and TH17 cells, as well as the polarisation of myeloid cells in the context of MS. The gene discussed is ANXA2; the disease is myeloid sarcoma.